Envestnet Asset Management Inc Neogenomics Inc Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 88,128 shares of NEO stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,128

Previous 94,691 6.93%

Holding current value

$1.19 Million

Previous $1.31 Million 1.07%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$13.4 - $17.73 $87,944 - $116,361	-6,563 Reduced 6.93%	88,128 $1.3 Million
Q2 2024 Aug 08, 2024	SELL	$13.01 - $15.77 $223,134 - $270,471	-17,151 Reduced 15.34%	94,691 $1.31 Million
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $52,795 - $63,046	3,755 Added 3.47%	111,842 $1.76 Million
Q4 2023 Feb 13, 2024	BUY	$11.67 - $20.73 $381,585 - $677,829	32,698 Added 43.37%	108,087 $1.75 Million
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $329,228 - $483,681	27,097 Added 56.11%	75,389 $927,000
Q2 2023 Aug 04, 2023	BUY	$14.1 - $19.83 $478,751 - $673,307	33,954 Added 236.81%	48,292 $776,000
Q1 2023 May 11, 2023	SELL	$9.09 - $19.45 $17,316 - $37,052	-1,905 Reduced 11.73%	14,338 $249,000
Q4 2022 Feb 07, 2023	SELL	$6.45 - $12.07 $68,266 - $127,748	-10,584 Reduced 39.45%	16,243 $150,000
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $113,223 - $185,968	-14,405 Reduced 34.94%	26,827 $231,000
Q2 2022 Aug 03, 2022	SELL	$7.06 - $13.97 $75,718 - $149,828	-10,725 Reduced 20.64%	41,232 $336,000
Q1 2022 May 04, 2022	SELL	$12.15 - $35.28 $376,309 - $1.09 Million	-30,972 Reduced 37.35%	51,957 $631,000
Q4 2021 Feb 04, 2022	SELL	$30.49 - $48.49 $53,174 - $84,566	-1,744 Reduced 2.06%	82,929 $2.83 Million
Q3 2021 Oct 07, 2021	SELL	$41.66 - $52.52 $1.06 Million - $1.34 Million	-25,555 Reduced 23.18%	84,673 $4.09 Million
Q2 2021 Aug 04, 2021	BUY	$36.62 - $51.69 $55,699 - $78,620	1,521 Added 1.4%	110,228 $4.98 Million
Q1 2021 May 04, 2021	BUY	$41.56 - $59.88 $2.42 Million - $3.48 Million	58,146 Added 115.0%	108,707 $5.24 Million
Q4 2020 Feb 02, 2021	SELL	$36.08 - $56.47 $115,816 - $181,268	-3,210 Reduced 5.97%	50,561 $2.72 Million
Q3 2020 Oct 09, 2020	BUY	$33.26 - $40.48 $137,197 - $166,980	4,125 Added 8.31%	53,771 $1.98 Million
Q2 2020 Jul 08, 2020	BUY	$24.21 - $31.02 $225,782 - $289,292	9,326 Added 23.13%	49,646 $1.54 Million
Q1 2020 Apr 23, 2020	SELL	$20.5 - $34.53 $192,618 - $324,443	-9,396 Reduced 18.9%	40,320 $1.11 Million
Q4 2019 Feb 11, 2020	BUY	$18.96 - $29.84 $187,438 - $294,998	9,886 Added 24.82%	49,716 $1.45 Million
Q3 2019 Oct 17, 2019	BUY	$19.12 - $26.24 $55,868 - $76,673	2,922 Added 7.92%	39,830 $762,000
Q2 2019 Aug 02, 2019	BUY	$19.57 - $24.1 $182,177 - $224,346	9,309 Added 33.73%	36,908 $810,000
Q1 2019 May 10, 2019	BUY	$12.14 - $20.46 $81,835 - $137,920	6,741 Added 32.32%	27,599 $565,000
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $234,443 - $385,873	20,858 New	20,858 $263,000

Others Institutions Holding NEO

# of Institutions

293

Shares Held

124M

Call Options Held

698K

Put Options Held

116K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Neogenomics Inc Transaction History